O Shaughnessy Asset Management LLC Sells 12,564 Shares of Ventas, Inc. $VTR

O Shaughnessy Asset Management LLC decreased its position in shares of Ventas, Inc. (NYSE:VTR) by 8.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 143,839 shares of the real estate investment trust’s stock after selling 12,564 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Ventas were worth $11,130,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. Bridgewater Advisors Inc. increased its position in Ventas by 2.0% during the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after acquiring an additional 133 shares during the last quarter. True Wealth Design LLC grew its holdings in shares of Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 138 shares during the last quarter. Cigna Investments Inc. New grew its holdings in shares of Ventas by 3.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after purchasing an additional 142 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of Ventas by 4.6% in the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after purchasing an additional 175 shares during the last quarter. Finally, HighTower Advisors LLC grew its holdings in shares of Ventas by 0.4% in the third quarter. HighTower Advisors LLC now owns 42,092 shares of the real estate investment trust’s stock worth $2,946,000 after purchasing an additional 182 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on VTR. Mizuho set a $98.00 price target on shares of Ventas in a report on Friday, May 22nd. The Goldman Sachs Group restated a “buy” rating and issued a $110.00 price target on shares of Ventas in a report on Tuesday, May 19th. Royal Bank Of Canada upped their price target on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. JPMorgan Chase & Co. upped their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, Scotiabank upped their price target on shares of Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a report on Thursday, May 21st. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and an average price target of $95.19.

Ventas Trading Up 2.6%

NYSE VTR opened at $84.65 on Thursday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 12 month low of $61.76 and a 12 month high of $91.06. The company’s 50-day moving average price is $85.06 and its 200-day moving average price is $82.44. The stock has a market cap of $41.15 billion, a PE ratio of 153.91, a PEG ratio of 1.77 and a beta of 0.71.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the company earned $0.84 earnings per share. The firm’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities research analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is presently 378.18%.

Insider Activity

In other Ventas news, Director Michael J. Embler bought 2,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the acquisition, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by corporate insiders.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.